This week is last stand for growth stock earnings hopes
Going into this earnings season, the hope was that strong, surprisingly strong perhaps, earnings from the big growth stocks would put a stop to the selling. Earnings would be strong enough to convince investors that the market wasn’t over-valued since at these...
AbbVie continues its run–picks up momentum from Allergan results
Shares of AbbVie (ABBV) tacked on another 1.32% today to a close at $96 continuing a run that began back on January 31 at $81.02. The trend picked up momentum on February 7 after the company reported fourth quarter earnings with better than expected sales for its...
Buying AbbVie today for my Dividend Portfolio with its 5.62% yield
Yesterday when the market was a sea of red, shares of AbbVie (ABBV) were a small beacon of green. Today when, as of 3:40 p.m. most of the market is green, AbbVie is a small spark of red. What’s up? AbbVie was higher yesterday on speculation that a cocktail of...Jim’s Daily Email Alerts:
Every post from Jubak Picks straight to your mailbox. And they're free!